Skip to main content
Log in

Sex hormone-induced mammary carcinogenesis in the female Noble rats: Expression of Bcl-2 and Bax in hormonal mammary carcinogenesis

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

We have established a Noble rat model to explore the mechanisms of hormonal mammary carcinogenesis, in which the role of androgen in promoting mammary carcinogenesis was highlighted. We have also established that stromal-epithelial interactions may be responsible for the promotional effects of testosterone in mammary carcinogenesis. Based on these understandings, in the present study we examined the expression of Bcl-2 and Bax in pre-malignant mammary glands from rats treated with different protocols of sex hormones for 7 weeks as well as sex hormone induced mammary tumours. We observed that Bcl-2 was strongly expressed in most of mammary tumour cells, whereas weak or negative in adjacent normal or hyperplastic ductal structures. On the contrary, Bax immunoreactivity was weak in mammary tumour cells while strongly expressed in adjacent normal or hyperplastic ductal structures. More importantly, the results from comparative study of ‘pre-malignant’ glands further showed that when animals were treated with 17β-oestradiol, the mammary epithelial cells expressed high levels of Bcl-2. The results from rats treated with testosterone, either alone or in combination with oestrogen, give rise to high levels of Bax expression in ‘pre-malignant’ mammary glands. These observations indicate that in ‘pre-malignant’ mammary glands, treatment with testosterone, either alone or in combination with 17β-oestradiol, may induce high apoptotic activities. However, in fully developed mammary tumours, the apoptotic activities apparently decrease in tumour cells. TUNEL assay provides further data to support this conclusion. Our study, thus, suggests that androgens may play a promoting role in mammary carcinogenesis by upregulation of Bax expression and induction of high apoptotic activities in ‘pre-malignant’ stage, which would provide a selective pressure favouring the expansion of the initiated cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics 1997. CA Cancer J Clin 47: 5–27, 1997

    PubMed  Google Scholar 

  2. Boyle P: Epidemiology of breast cancer. Bailliere's Clin Oncol 2: 1–8, 1998

    Google Scholar 

  3. Dickson RB, Lippman ME: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 8: 29–43, 1987

    PubMed  Google Scholar 

  4. Horwitz KB, McGuire WL: Nuclear mechanism of estrogen action. Effect of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J Biol Chem 253: 8185–8191, 1978

    PubMed  Google Scholar 

  5. Rochefort H, Garcia M: The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther 23: 193–216, 1983

    PubMed  Google Scholar 

  6. Kesey JL: Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15: 256–263, 1993

    PubMed  Google Scholar 

  7. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G: Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88: 291–296, 1996

    PubMed  Google Scholar 

  8. Secreto G, Toniolo P, Berrino F, Recchine C, Cavalleri A, Pisani P, Totis A, Fariselli G, DiPietro S: Serum and urinary androgens and risk of breast cancer in postmanopausal women. Cancer Res 51: 2572–2576, 1991

    PubMed  Google Scholar 

  9. Secreto G, Toniolo P, Berrino F, Recchione C, DiPietro S, Fariselli G, Decarli A: Increased androgen activity and breast cancer risk in premanopausal women. Cancer Res 44: 5902–5905, 1984

    Google Scholar 

  10. Veronesi U, Pizzocaro G: Breast cancer in women subsequent to cystic disease of the breast. Surg Gynecol Obstet 126: 529–532, 1968

    PubMed  Google Scholar 

  11. Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A: Serum sex hormone levels are related to breast cancer risk in postmenopausal women. Environ Health Perspectives 105(Suppl): 583–585, 1997

    Google Scholar 

  12. Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller P, Franz C: Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 5: 533–539, 1996

    PubMed  Google Scholar 

  13. Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, van der Kwast TH: Androgen receptor expression in human tissues: an immunohistochemical study. J Histochem Cytochem 39: 927, 1991

    PubMed  Google Scholar 

  14. Janssen PJ, Brinkmann AO, Boersma WJ, van der Kwast TH: Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in rountinely processed, paraffin-embedded human tissues after microwave pre-treatment. J Histochem Cytochem 42: 1169–1175, 1994

    PubMed  Google Scholar 

  15. Kimura N, Mizokami A: Immunocytochemical localization of androgen receptors with polyclonal antibody in paraffinembedded human tissues. J Histochem Cytochem 42: 126, 1994

    Google Scholar 

  16. Lea OA, Kvinnsland S, Thorsen T: Improved measurement of androgen receptors in human breast cancer. Cancer Res 49: 7162–7167, 1989

    PubMed  Google Scholar 

  17. Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer 54: 2436–2440, 1984

    PubMed  Google Scholar 

  18. Soreide JA, Lea OA, Varhaug JE, Skarstein A, Kvinnsland S: Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlation to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Eur J Surg Oncol 18: 112–118, 1992

    PubMed  Google Scholar 

  19. Coleman WB, Tsongalis GJ: Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin Chem 41: 644–657, 1995

    PubMed  Google Scholar 

  20. Krajewski S, Krajewski M, Shabaik A, Miyashita T, Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Pathol 145: 1323–1336, 1994

    PubMed  Google Scholar 

  21. Lu PJ, Lu QL, Rughetti A, Taylor-Papadimitriou J: bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J Cell Biol 129: 1363–1378, 1995

    PubMed  Google Scholar 

  22. Schwarze MMK, Hawley RG: Prevention of myeloma cell apoptosis by ectopic expression of bcl-2 or inter leukin 6-mediated upregulation of bcl-XL. Cancer Res 55: 2262–2265, 1995

    PubMed  Google Scholar 

  23. Hockenbery DM: bcl-2 in cancer: development and apoptosis. J Cell Sci 107: 51–55, 1994

    Google Scholar 

  24. Reed JC: bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1–6, 1994

    PubMed  Google Scholar 

  25. Steller H: Mechanisms and genes of cellular suicide. Science 267: 1445–1449, 1995

    PubMed  Google Scholar 

  26. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates cell death. Cell 74: 609–619, 1993

    PubMed  Google Scholar 

  27. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285–291, 1995

    PubMed  Google Scholar 

  28. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ: Multiple Bcl–2 family members demonstrate selective dimerixation with Bax. Proc Natl Acad Sci USA 92: 7834–7838, 1995

    PubMed  Google Scholar 

  29. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang HG, Reed JC: Interaction among members of the Bcl–2 protein family analyzed with the yeast two-hybrid system. Proc Natl Acad Sci USA 91: 9238–9242, 1994

    PubMed  Google Scholar 

  30. Oltvai ZN, Korsmeyer SJ: Checkpoints of dueling dimers foil death wishes. Cell 79: 189–192, 1994

    PubMed  Google Scholar 

  31. Lu Q, Abel P, Foster CS, Lalani E: bcl-2: Role in epithelial differentiation and oncogenesis. Hum Pathol 27: 102–110, 1996

    PubMed  Google Scholar 

  32. Sabourin JC, Martin A, Baruch J, Truc JB, Gompel A, Poitout P: bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 59: 1–6, 1994

    PubMed  Google Scholar 

  33. Wong YC, Xie B, Tsao SW: 1999 Induction of breast cancer in Noble rats with a combination of estrogen and testosterone. In: Li JJ, Daling J, Li SA (eds) Hormonal Carcinogenesis, vol. 3, Springer-Verlag (in press)

  34. Xie B, Tsao SW, Wong YC: Induction of high incidence of mammary tumor in female Noble rats with a combination of 17b-oestradiol and testosterone. Carcinogenesis 20: 1069–1078, 1999

    PubMed  Google Scholar 

  35. Liao DJ, Hou X, Pantazis C, Bai S, Li SA, Li JJ: Combined treatment of estrogen and androgen is more effective than estrogen alone in induction of mammary adenocarcinoma in the male Noble rat. Am Asso Cancer Res 39: 387, 1998

    Google Scholar 

  36. Liao DJ, Pantazis CG, Hou X, Li SA: Promotion of estrogeninduced mammary gland carcinogenesis by androgen in the male Noble rat: Probable mediation by steroid receptor. Carcinogenesis 19: 2173–2180, 1998

    PubMed  Google Scholar 

  37. Rosen PP: Rosen's breast pathology. Lippincott-Raven, New York, 1997

    Google Scholar 

  38. Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ: Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88: 1054–1059, 1996

    PubMed  Google Scholar 

  39. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493–501, 1992

    PubMed  Google Scholar 

  40. SPSS: SPSS Base 7.0 for Windows User's Guide. SPSS Inc., Chicago, IL, 1996

    Google Scholar 

  41. Xie B, Tsao SW, Wong YC: Sex hormone-induced mammary carcinogenesis in female Noble rats: the role of androgens. Carcinogenesis 20: 1597–1606, 1999

    PubMed  Google Scholar 

  42. van Slooten HJ, van de Vijver MJ, van de Velde CJ, van Dierendock JH: Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer 77: 789–796, 1998

    PubMed  Google Scholar 

  43. Binder C, Marx D, Binder L, Schauer A, Hiddemann W: Expression of Bax in relation to Bcl-2 and other predictive parameters in breast cancer. Ann Oncol 7: 129–133, 1996

    PubMed  Google Scholar 

  44. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3: 614–620, 1997

    PubMed  Google Scholar 

  45. Teixeira C, Reed JC, Pratt MA: Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55: 3902–3907, 1995

    PubMed  Google Scholar 

  46. Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A, Bhalla K: Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MDF-7 cells. Breast Cancer Res Treat 42: 73–81, 1997

    PubMed  Google Scholar 

  47. Lapointe J, Fournier A, Richard V, Labrie C: Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells. Endocrinology 140: 416–421, 1999

    PubMed  Google Scholar 

  48. Shen KL, Harn HJ, Ho L, Yu CP, Chiu SC, Lee WH: The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and 57 terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling. Cancer 82: 2373–2381, 1998

    PubMed  Google Scholar 

  49. Akhurst RJ, Balmain A: Genetic events and the role of TGFb in epithelial tumor progression. J Pathol 187: 82–90, 1999

    PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, B., Tsao, S. & Wong, Y. Sex hormone-induced mammary carcinogenesis in the female Noble rats: Expression of Bcl-2 and Bax in hormonal mammary carcinogenesis. Breast Cancer Res Treat 61, 45–57 (2000). https://doi.org/10.1023/A:1006400732154

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006400732154

Navigation